Management of Juvenile myasthenia gravis

Pediatric Neurology

Volumn 48, Issue 2, 2013, Pages 95-104

  Ionita, Cristian M ^a   Acsadi, Gyula ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMBENONIUM; AZATHIOPRINE; CHOLINESTERASE INHIBITOR; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEOSTIGMINE; PREDNISOLONE; PREDNISONE; PYRIDOSTIGMINE; RITUXIMAB; TACROLIMUS;

ABDOMINAL CRAMP; ADOLESCENT DISEASE; BRADYCARDIA; CHILL; CLINICAL EFFECTIVENESS; CORTICOSTEROID THERAPY; DIARRHEA; DIET THERAPY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; FASCICULATION; FATIGUE; GROUPS BY AGE; HEADACHE; HUMAN; HYPERHIDROSIS; HYPERSALIVATION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; LIFESTYLE MODIFICATION; LONG TERM CARE; LOW DRUG DOSE; MUSCLE CRAMP; MYASTHENIA GRAVIS; NAUSEA; PLASMAPHERESIS; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; SEX DIFFERENCE; THYMECTOMY;

ADOLESCENT; AGE OF ONSET; CHILD; CHOLINESTERASE INHIBITORS; HUMANS; IMMUNOSUPPRESSION; MYASTHENIA GRAVIS; THYMECTOMY;

EID: 84872798800     PISSN: 08878994     EISSN: 18735150     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2012.07.008     Document Type: Review

References (85)

1. L.H. Phillips Jr., J.C. Torner, M.S. Anderson, and G.M. Cox The epidemiology of myasthenia gravis in central and western Virginia Neurology 42 1992 1888 1893
2. P.I. Andrews, J.M. Massey, J.F. Howard Jr., and D.B. Sanders Race, sex, and puberty influence onset, severity, and outcome in juvenile myasthenia gravis Neurology 44 1994 1208 1214 (Pubitemid 24232216)
3. H.C. Chiu, A. Vincent, J. Newsom-Davis, K.H. Hsieh, and T. Hung Myasthenia gravis: Population differences in disease expression and acetylcholine receptor antibody titers between Chinese and Caucasians Neurology 37 1987 1854 1857 (Pubitemid 18026365)
4. P.I. Andrews A treatment algorithm for autoimmune myasthenia gravis in childhood Ann NY Acad Sci 841 1998 789 802 (Pubitemid 28362940)
5. A.P. Batocchi, A. Evoli, M.T. Palmisani, M. Lo Monaco, M. Bartoccioni, and P. Tonali Early-onset myasthenia gravis: Clinical characteristics and response to therapy Eur J Pediatr 150 1990 66 68
6. A. Evoli, A.P. Batocchi, E. Bartoccioni, M.M. Lino, C. Minisci, and P. Tonali Juvenile myasthenia gravis with prepubertal onset Neuromuscul Disord 8 1998 561 567 (Pubitemid 28555738)
7. S. Ortiz, and M. Borchert Long-term outcomes of pediatric ocular myasthenia gravis Ophthalmology 115 2008 1245 1248
8. F. Scuderi, M. Marino, and L. Colonna Anti-p110 autoantibodies identify a subtype of "seronegative" myasthenia gravis with prominent oculobulbar involvement Lab Invest 82 2002 1139 1146 (Pubitemid 35014847)
9. J.T. Guptill, and D.B. Sanders Update on muscle-specific tyrosine kinase antibody positive myasthenia gravis Curr Opin Neurol 23 2010 530 535
10. M. Pasnoor, G.I. Wolfe, and S. Nations Clinical findings in MuSK-antibody positive myasthenia gravis: A U.S. experience Muscle Nerve 41 2009 370 374
11. B. Anlar, and A. Vincent Antibodies against muscle-specific kinase in juvenile myasthenia gravis Neuropediatrics 34 2003 110 111 (Pubitemid 36597133)
12. A. Evoli, M.R. Bianchi, and R. Riso Response to therapy in myasthenia gravis with anti-MuSK antibodies Ann NY Acad Sci 1132 2008 76 83 (Pubitemid 351841355)
13. B. Saulat, P. Maertens, W.J. Hamilton, and B.A. Bassam Anti-MuSK antibody after thymectomy in a previously seropositive myasthenic child Neurology 69 2007 803 804 (Pubitemid 47300939)
14. M. Rodriguez, M.R. Gomez, F.M. Howard Jr., and W.F. Taylor Myasthenia gravis in children: Long-term follow-up Ann Neurol 13 1983 504 510 (Pubitemid 13086668)
15. A. Lindner, B. Schalke, and K.V. Toyka Outcome in juvenile-onset myasthenia gravis: A retrospective study with long-term follow-up of 79 patients J Neurol 244 1997 515 520 (Pubitemid 27424791)
16. J.H. Kim, J.M. Hwang, Y.S. Hwang, K.J. Kim, and J. Chae Childhood ocular myasthenia gravis Ophthalmology 110 2003 1458 1462 (Pubitemid 36842490)
17. S.L. Pineles, R.A. Avery, and H.E. Moss Visual and systemic outcomes in pediatric ocular myasthenia gravis Am J Ophthalmol 150 2010 453 459
18. P. Mullaney, J. Vajsar, R. Smith, and J.R. Buncic The natural history and ophthalmic involvement in childhood myasthenia gravis at the Hospital for Sick Children Ophthalmology 107 2000 504 510 (Pubitemid 30191373)
19. M. Pitt Neurophysiological strategies for the diagnosis of disorders of the neuromuscular junction in children Dev Med Child Neurol 50 2008 328 333 (Pubitemid 351560291)
20. M. Benatar A systematic review of diagnostic studies in myasthenia gravis Neuromuscul Disord 16 2006 459 467 (Pubitemid 44094102)
21. P.I. Andrews Autoimmune myasthenia gravis in childhood Semin Neurol 24 2004 101 110 (Pubitemid 38823784)
22. M. Walker Treatment of myasthenia gravis with physostigmine Lancet 223 1934 1200 1201
23. U. Luchanok, and H.J. Kaminski Ocular myasthenia: Diagnostic and treatment recommendations and the evidence base Curr Opin Neurol 21 2008 8 15
24. A. Jani-Acsadi, and R.P. Lisak Myasthenia gravis Curr Treat Options Neurol 12 2010 231 243
25. D.B. Sanders, K. El-Salem, J.M. Massey, J. McConville, and A. Vincent Clinical aspects of MuSK antibody positive seronegative MG Neurology 60 2003 1978 1980 (Pubitemid 36736017)
26. J.T. Guptill, D.B. Sanders, and A. Evoli Anti-MuSK antibody myasthenia gravis: Clinical findings and response to treatment in two large cohorts Muscle Nerve 44 2011 36 40
27. A.R. Punga, M. Sawada, and E.V. Stalberg Electrophysiological signs and the prevalence of adverse effects of acetylcholinesterase inhibitors in patients with myasthenia gravis Muscle Nerve 37 2008 300 307 (Pubitemid 351304789)
28. P. Cavalcante, R. Le Panse, and S. Berrih-Aknin The thymus in myasthenia gravis: Site of "innate autoimmunity"? Muscle Nerve 44 2011 467 484
29. P. Cavalcante, L. Maggi, and L. Colleoni Inflammation and Epstein-Barr virus infection are common features of myasthenia gravis thymus: Possible roles in pathogenesis Autoimmune Dis 2011 2011 1 17
30. J. Newsom-Davis, G. Cutter, and G.I. Wolfe Status of the thymectomy trial for nonthymomatous myasthenia gravis patients receiving prednisone Ann NY Acad Sci 1132 2008 344 347 (Pubitemid 351841357)
31. C. Adams, D. Theodorescu, E.G. Murphy, and B. Shandling Thymectomy in juvenile myasthenia gravis J Child Neurol 5 1990 215 218 (Pubitemid 20274286)
32. M.E. Seybold Thymectomy in childhood myasthenia gravis Ann NY Acad Sci 841 1998 731 741 (Pubitemid 28362930)
33. M.M. Tracy, W. McRae, and J.G. Millichap Graded response to thymectomy in children with myasthenia gravis J Child Neurol 24 2009 454 459
34. J.B. Shrager, D. Nathan, and C.J. Brinster Outcomes after 151 extended transcervical thymectomies for myasthenia gravis Ann Thorac Surg 82 2006 1863 1869 (Pubitemid 44584915)
35. X. Liang, M.A. Lovell, and K.E. Capocelli Thymoma in children: Report of 2 cases and review of the literature Pediatr Dev Pathol 13 2010 202 208
36. W.L. Furman, P.J. Buckley, A.A. Green, D.C. Stokes, and L.T. Chien Thymoma and myasthenia gravis in a 4-year-old child: Case report and review of the literature Cancer 56 1985 2703 2706 (Pubitemid 16249938)
37. J.B. Ghosh, M. Roy, and T. Peters Thymoma associated with myasthenia gravis in infancy Indian J Pediatr 76 2009 1057 1058
38. D. Sauce, M. Larsen, and S. Fastenackels Evidence of premature immune aging in patients thymectomized during early childhood J Clin Invest 119 2009 3070 3078
39. V.V. Ashraf, A.B. Taly, M. Veerendrakumar, and S. Rao Myasthenia gravis in children: A longitudinal study Acta Neurol Scand 114 2006 119 123 (Pubitemid 44034260)
40. T.L. Ware, M.M. Ryan, and A.J. Kornberg Autoimmune myasthenia gravis, immunotherapy and thymectomy in children Neuromuscul Disord 22 2011 118 121
41. A. Jaretzki III Thymectomy for myasthenia gravis: Analysis of controversies - Patient management Neurologist 9 2003 77 92
42. H.K. Kolski, P.C. Kim, and J. Vajsar Video-assisted thoracoscopic thymectomy in juvenile myasthenia gravis J Child Neurol 16 2001 569 573 (Pubitemid 32798879)
43. J.B. Shrager Extended transcervical thymectomy: The ultimate minimally invasive approach Ann Thorac Surg 89 Suppl. 2010 S2128 S2134
44. J.M. Ponseti, J. Gamez, and R. Vilallonga Influence of ectopic thymic tissue on clinical outcome following extended thymectomy in generalized seropositive nonthymomatous myasthenia gravis Eur J Cardiothorac Surg 34 2008 1062 1067
45. S. Jolles, W.A. Sewell, and S.A. Misbah Clinical uses of intravenous immunoglobulin Clin Exp Immunol 142 2005 1 11 (Pubitemid 41360999)
46. P. Gajdos, S. Chevret, B. Clair, C. Tranchant, and C. Chastang Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Myasthenia Gravis Clinical Study Group Ann Neurol 41 1997 789 796 (Pubitemid 27249184)
47. D. Barth, M. Nabavi Nouri, E. Ng, P. Nwe, and V. Bril Comparison of IVIG and PLEX in patients with myasthenia gravis Neurology 76 2011 2017 2023
48. L. Zinman, and V. Bril IVIG treatment for myasthenia gravis: Effectiveness, limitations, and novel therapeutic strategies Ann NY Acad Sci 1132 2008 264 270 (Pubitemid 351841378)
49. D. Selcen, E.R. Dabrowski, A.M. Michon, and M.A. Nigro High-dose intravenous immunoglobulin therapy in juvenile myasthenia gravis Pediatr Neurol 22 2000 40 43 (Pubitemid 30045603)
50. D.N. Herrmann, P.R. Carney, and J.J. Wald Juvenile myasthenia gravis: Treatment with immune globulin and thymectomy Pediatr Neurol 18 1998 63 66 (Pubitemid 28082398)
51. C. Heatwole, N. Johnson, R. Holloway, and K. Noyes Plasma exchange versus intravenous immunoglobulin for myasthenia gravis crisis: An acute hospital cost comparison study J Clin Neuromuscul Dis 13 2012 85 94
52. P. Gajdos, C. Tranchant, and B. Clair Treatment of myasthenia gravis exacerbation with intravenous immunoglobulin: A randomized double-blind clinical trial Arch Neurol 62 2005 1689 1693 (Pubitemid 41626664)
53. L.M. Chiang, B.T. Darras, and P.B. Kang Juvenile myasthenia gravis Muscle Nerve 39 2009 423 431
54. C. Schneider-Gold, P. Gajdos, K.V. Toyka, and R.R. Hohlfeld Corticosteroids for myasthenia gravis Cochrane Database Syst Rev 2 2005 CD002828
55. R.M. Pascuzzi, H.B. Coslett, and T.R. Johns Long-term corticosteroid treatment of myasthenia gravis: Report of 116 patients Ann Neurol 15 1984 291 298 (Pubitemid 14164748)
56. C. Lindberg, O. Andersen, S. Larsson, and A. Oden Remission rate after thymectomy in myasthenia gravis when the bias of immunosuppressive therapy is eliminated Acta Neurol Scand 86 1992 323 328
57. M.J. Kupersmith Ocular myasthenia gravis: Treatment successes and failures in patients with long-term follow-up J Neurol 256 2009 1314 1320
58. J. Palace, J. Newsom-Davis, and B. Lecky A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis: Myasthenia Gravis Study Group Neurology 50 1998 1778 1783 (Pubitemid 28283251)
59. B. Badurska, B. Ryniewicz, and H. Strugalska Immunosuppressive treatment for juvenile myasthenia gravis Eur J Pediatr 151 1992 215 217
60. Mantegazza R, Antozzi C, Peluchetti D, Sghirlanzoni A, Cornelio F. Azathioprine as a single drug or in combination with steroids in the treatment of myasthenia gravis. J Neurol 988;235:449-53.
61. V. Cosi, M. Lombardi, A. Erbetta, and G. Piccolo Azathioprine as a single immunosuppressive drug in the treatment of myasthenia gravis Acta Neurol (Napoli) 15 1993 123 131 (Pubitemid 23177967)
62. D.B. Sanders, and A. Evoli Immunosuppressive therapies in myasthenia gravis Autoimmunity 43 2010 428 435
63. P. Karran, and N. Attard Thiopurines in current medical practice: Molecular mechanisms and contributions to therapy-related cancer Nat Rev Cancer 8 2008 24 36
64. R.S. Tindall, J.T. Phillips, J.A. Rollins, L. Wells, and K. Hall A clinical therapeutic trial of cyclosporine in myasthenia gravis Ann NY Acad Sci 681 1993 539 551 (Pubitemid 23233874)
65. E. Ciafaloni, N.K. Nikhar, J.M. Massey, and D.B. Sanders Retrospective analysis of the use of cyclosporine in myasthenia gravis Neurology 55 2000 448 450 (Pubitemid 30650092)
66. L.G. De Feo, J. Schottlender, N.A. Martelli, and N.A. Molfino Use of intravenous pulsed cyclophosphamide in severe, generalized myasthenia gravis Muscle Nerve 26 2002 31 36 (Pubitemid 34734393)
67. M.K. Hehir, T.M. Burns, J. Alpers, M.R. Conaway, M. Sawa, and D.B. Sanders Mycophenolate mofetil in AChR-antibody-positive myasthenia gravis: Outcomes in 102 patients Muscle Nerve 41 2010 593 598
68. D.B. Sanders, I.K. Hart, and R. Mantegazza An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis Neurology 71 2008 400 406
69. J.M. Heckmann, A. Rawoot, K. Bateman, R. Renison, and M. Badri A single-blinded trial of methotrexate versus azathioprine as steroid-sparing agents in generalized myasthenia gravis BMC Neurol 11 2011 97
70. Y. Furukawa, H. Yoshikawa, K. Iwasa, and M. Yamada Clinical efficacy and cytokine network-modulating effects of tacrolimus in myasthenia gravis J Neuroimmunol 195 2008 108 115
71. J.M. Ponseti, J. Gamez, J. Azem, M. Lopez-Cano, R. Vilallonga, and M. Armengol Tacrolimus for myasthenia gravis: A clinical study of 212 patients Ann NY Acad Sci 1132 2008 254 263 (Pubitemid 351841343)
72. K. Ishigaki, K. Shishikura, T. Murakami, H. Suzuki, Y. Hirayama, and M. Osawa Benefits of FK 506 for refractory eye symptoms in a young child with ocular myasthenia gravis Brain Dev 31 2009 634 637
73. Y. Kakisaka, K. Haginoya, and H. Yokoyama Successful treatment of a 2-year-old girl with intractable myasthenia gravis using tacrolimus Brain Dev 28 2006 534 536 (Pubitemid 44051812)
74. N. Zebardast, H.S. Patwa, S.P. Novella, and J.M. Goldstein Rituximab in the management of refractory myasthenia gravis Muscle Nerve 41 2010 375 378
75. C. Lebrun, V. Bourg, N. Tieulie, and P. Thomas Successful treatment of refractory generalized myasthenia gravis with rituximab Eur J Neurol 16 2009 246 250
76. M.E. Wylam, P.M. Anderson, N.L. Kuntz, and V. Rodriguez Successful treatment of refractory myasthenia gravis using rituximab: A pediatric case report J Pediatr 143 2003 674 677 (Pubitemid 37452801)
77. N. Tzaribachev, I. Koetter, J.B. Kuemmerle-Deschner, and J. Schedel Rituximab for the treatment of refractory pediatric autoimmune diseases: A case series Cases J 2 2009 6609
78. S. Jarius, F. Paul, and D. Franciotta Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: Ten new aquaporin-4 antibody positive cases and a review of the literature Mult Scler 18 2011 1135 1143
79. M. Dunand, S.A. Botez, F.X. Borruat, P. Roux-Lombard, F. Spertini, and T. Kuntzer Unsatisfactory outcomes in myasthenia gravis: Influence by care providers J Neurol 257 2010 338 343
80. A. Jaretzki III, R.J. Barohn, and R.M. Ernstoff Myasthenia gravis: Recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America Neurology 55 2000 16 23
81. B. Anlar, N. Senbil, G. Kose, and A. Degerliyurt Serological follow-up in juvenile myasthenia: Clinical and acetylcholine receptor antibody status of patients followed for at least 2 years Neuromuscul Disord 15 2005 355 357
82. K.E. Osserman, and G. Genkins Studies in myasthenia gravis: Review of a twenty-year experience in over 1200 patients Mt Sinai J Med (NY) 38 1971 497 537
83. X. Zhang, M. Yang, and J. Xu Clinical and serological study of myasthenia gravis in HuBei Province, China J Neurol Neurosurg Psychiatry 78 2007 386 390 (Pubitemid 46580547)
84. I.K. Hart, T. Sharshar, and S. Sathasivam Immunosuppressant drugs for myasthenia gravis J Neurol Neurosurg Psychiatry 80 2009 5 6
85. I.A. Hennessey, A.M. Long, I. Hughes, and G. Humphrey Thymectomy for inducing remission in juvenile myasthenia gravis Pediatr Surg Int 27 2011 591 594